Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitazoxanide and Oseltamivir in Acute Uncomplicated Influenza
NCT01610245Phase 3Completed
- Sponsor
- Romark Laboratories
- Start
- Mar 2013
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Phase 3, randomised, double-blind trial of nitazoxanide in influenza (4 arms), sponsored by Romark Laboratories. Primary endpoint: Time to resolution of all clinical symptoms of influenza at 28 days. Started Mar 2013; status: completed.
02
Drugs
nitazoxanide
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01610245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01610245.